Shares of DepoMed (DEPO) sink after the drug maker discloses a potentially damaging contract...

|By:, SA News Editor

Shares of DepoMed (DEPO) sink after the drug maker discloses a potentially damaging contract dispute with Abbott Labs (ABT) over the marketing of a shingles drug. DEPO -12.8% premarket. (PR)